Minocycline Hydrochloride Patent Expiration
Minocycline Hydrochloride was first introduced by Triax Pharmaceuticals Llc
Minocycline Hydrochloride Patents
Given below is the list of patents protecting Minocycline Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Amzeeq | US10086080 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Amzeeq | US10137200 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
| Amzeeq | US10213512 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Amzeeq | US10265404 | Compositions, gels and foams with rheology modulators and uses thereof | Oct 01, 2030 | Journey |
| Amzeeq | US10398641 | Compositions and methods for treating rosacea and acne | Sep 08, 2037 | Journey |
| Amzeeq | US10517882 | Method for healing of an infected acne lesion without scarring | Oct 01, 2030 | Journey |
| Amzeeq | US10821187 | Compositions, gels and foams with rheology modulators and uses thereof | Oct 01, 2030 | Journey |
| Amzeeq | US10849847 | Compositions and methods for treating rosacea and acne | Sep 08, 2037 | Journey |
| Amzeeq | US8865139 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Amzeeq | US8945516 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
| Amzeeq | US8992896 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Amzeeq | US9675700 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Arestin | US6682348 | Dispensing apparatus and cartridge |
Mar 29, 2022
(Expired) | Orapharma |
| Arestin | US7699609 | Dispensing apparatus and cartridge with deformable tip |
Mar 29, 2022
(Expired) | Orapharma |
| Minocin | US11944634 | Tetracycline compositions | Oct 16, 2032 | Rempex |
| Minocin | US9084802 | Tetracycline compositions | May 12, 2031 | Rempex |
| Minocin | US9278105 | Tetracycline compositions | May 12, 2031 | Rempex |
| Minolira | US11103517 | Pharmaceutical compositions for minocycline | Apr 07, 2036 | Epi Hlth |
| Solodyn | US5908838 | Method for the treatment of acne |
Feb 19, 2018
(Expired) | Bausch |
| Solodyn | US7541347 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Bausch |
| Solodyn | US7544373 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Bausch |
| Solodyn | US7790705 | Minocycline oral dosage forms for the treatment of acne | Jun 24, 2025 | Bausch |
| Solodyn | US7919483 | Method for the treatment of acne | Mar 07, 2027 | Bausch |
| Solodyn | US8252776 | Minocycline oral dosage forms for the treatment of acne | Jun 24, 2025 | Bausch |
| Solodyn | US8268804 | Minocycline oral dosage forms for the treatment of acne | Jun 24, 2025 | Bausch |
| Solodyn | US8722650 | Extended-release minocycline dosage forms | Jun 24, 2025 | Bausch |
| Solodyn | US9192615 | Method for the treatment of acne and certain dosage forms thereof | Nov 17, 2031 | Bausch |
| Ximino | US5908838 | Method for the treatment of acne |
Feb 19, 2018
(Expired) | Journey |
| Ximino | US7541347 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Journey |
| Ximino | US7544373 | Minocycline oral dosage forms for the treatment of acne | Apr 02, 2027 | Journey |
| Ximino | US7790705 | Minocycline oral dosage forms for the treatment of acne | Jun 24, 2025 | Journey |
| Ximino | US7919483 | Method for the treatment of acne | Mar 07, 2027 | Journey |
| Ximino | US8252776 | Minocycline oral dosage forms for the treatment of acne | Jun 24, 2025 | Journey |
| Ximino | US8268804 | Minocycline oral dosage forms for the treatment of acne | Jun 24, 2025 | Journey |
| Zilxi | US10213512 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Zilxi | US10265404 | Compositions, gels and foams with rheology modulators and uses thereof | Oct 01, 2030 | Journey |
| Zilxi | US10322186 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Zilxi | US10946101 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
| Zilxi | US8865139 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Zilxi | US8945516 | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses | Oct 01, 2030 | Journey |
| Zilxi | US8992896 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
| Zilxi | US9675700 | Topical tetracycline compositions | Oct 01, 2030 | Journey |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Minocycline Hydrochloride's patents.
Latest Legal Activities on Minocycline Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Minocycline Hydrochloride.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Feb, 2024 | US8268804(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 23 Jan, 2024 | US8252776(Litigated) |
| Payment of Maintenance Fee, 8th Year, Large Entity | 20 Apr, 2023 | US9192615 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 19 Dec, 2022 | US10322186 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 20 Sep, 2022 | US7919483(Litigated) |
| Payment of Maintenance Fee, 12th Year, Large Entity | 23 Feb, 2022 | US7790705(Litigated) |
| Recordation of Patent Grant Mailed | 16 Mar, 2021 | US10946101 |
| Patent Issue Date Used in PTA Calculation | 16 Mar, 2021 | US10946101 |
| Email Notification | 26 Feb, 2021 | US10946101 |
| Issue Notification Mailed | 24 Feb, 2021 | US10946101 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Minocycline Hydrochloride Generics
Several generic applications have been filed for Minocycline Hydrochloride. The first generic version for Minocycline Hydrochloride was by Lederle Laboratories Div American Cyanamid Co and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Jun 16, 2023.
Given below is the list of companies who have filed for Minocycline Hydrochloride generic.
1. BEXIMCO PHARMS USA
Beximco Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Beximco Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | May 27, 2022 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | May 27, 2022 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | May 27, 2022 |
2. IMPAX LABS
Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 23, 1999 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 23, 1999 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Apr 18, 2001 |
3. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | Apr 16, 2003 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Apr 16, 2003 |
| EQ 100MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | Apr 16, 2003 |
4. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2008 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2008 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 11, 2008 |
5. TORRENT
Torrent Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jan 6, 2004 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jan 6, 2004 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | Jan 6, 2004 |
6. SUN PHARM INDS INC
Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | May 13, 2013 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | May 13, 2013 |
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | May 13, 2013 |
7. MEDICIS
Medicis Pharmaceutical Corp has filed for 1 generic for Minocycline Hydrochloride. This eq 50mg base version comes by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Medicis.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Aug 14, 1990 |
8. WATSON LABS
Watson Laboratories Inc has filed for 2 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Prescription | ORAL | AB | Dec 30, 1991 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Jun 10, 1999 |
9. SIDMAK LABS INDIA
Sidmak Laboratories India Pvt Ltd has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sidmak Labs India.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG BASE | tablet, extended release | Prescription | ORAL | AB | Dec 30, 2015 |
| EQ 80MG BASE | tablet, extended release | Prescription | ORAL | AB | Dec 30, 2015 |
| EQ 105MG BASE | tablet, extended release | Prescription | ORAL | AB | Dec 30, 2015 |
| EQ 45MG BASE | tablet, extended release | Prescription | ORAL | AB | Dec 30, 2015 |
| EQ 65MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 7, 2022 |
| EQ 55MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 7, 2022 |
| EQ 115MG BASE | tablet, extended release | Prescription | ORAL | AB | Oct 7, 2022 |
10. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 25, 2014 |
| EQ 135MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 25, 2014 |
| EQ 105MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 25, 2014 |
| EQ 90MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 25, 2014 |
| EQ 80MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Sep 25, 2014 |
| EQ 115MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Dec 3, 2019 |
| EQ 65MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Dec 3, 2019 |
11. ZYDUS
Zydus Worldwide Dmcc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE
(reference standard) | capsule | Prescription | ORAL | AB | Mar 2, 1992 |
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Mar 2, 1992 |
| EQ 75MG BASE | capsule | Prescription | ORAL | AB | Aug 12, 2003 |
12. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 16, 2017 |
| EQ 80MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 16, 2017 |
| EQ 90MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 16, 2017 |
| EQ 105MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 16, 2017 |
| EQ 135MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Nov 16, 2017 |
| EQ 65MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 16, 2023 |
| EQ 115MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 16, 2023 |
| EQ 55MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 16, 2023 |
13. NEXUS PHARMS
Nexus Pharmaceuticals Inc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Nexus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | injectable | Prescription | INJECTION | AP | Jul 22, 2022 |
14. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 4 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2011 |
| EQ 55MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2011 |
| EQ 45MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2011 |
| EQ 90MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 30, 2011 |
15. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Dec 26, 2007 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Dec 26, 2007 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | Dec 26, 2007 |
16. SANDOZ
Sandoz Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 13, 2009 |
| EQ 135MG BASE
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Aug 13, 2009 |
| EQ 45MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 13, 2009 |
17. LEDERLE
Lederle Laboratories Div American Cyanamid Co has filed for 1 generic for Minocycline Hydrochloride. This eq 100mg base/vial version comes by the name MINOCIN. Given below are the details of the strengths of this generic introduced by Lederle.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | injectable | Discontinued | INJECTION | N/A | Approved Prior to Jan 1, 1982 |
18. SUN PHARM INDUSTRIES
Sun Pharmaceutical Industries Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Sun Pharm Industries.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | Jan 29, 2016 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | Jan 29, 2016 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | Jan 29, 2016 |
19. ALVOGEN
Alvogen Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. All of these versions come by the name DYNACIN. Given below are the details of the strengths of this generic introduced by Alvogen.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE | capsule | Discontinued | ORAL | N/A | Jul 31, 1990 |
| EQ 50MG BASE | capsule | Discontinued | ORAL | N/A | Aug 14, 1990 |
| EQ 75MG BASE | capsule | Discontinued | ORAL | N/A | Sep 15, 1999 |
20. IMPAX LABS INC
Impax Laboratories Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 45MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 3, 2009 |
| EQ 135MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 3, 2009 |
| EQ 90MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Feb 3, 2009 |
21. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jul 20, 2010 |
| EQ 90MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jul 20, 2010 |
| EQ 45MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jul 20, 2010 |
22. RISING
Rising Pharma Holdings Inc has filed for 5 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Aug 22, 2014 |
| EQ 105MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Aug 22, 2014 |
| EQ 115MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jul 30, 2019 |
| EQ 65MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jul 30, 2019 |
| EQ 55MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Aug 21, 2019 |
23. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 11 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 135MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 19, 2012 |
| EQ 90MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 19, 2012 |
| EQ 45MG BASE | tablet, extended release | Prescription | ORAL | AB | Nov 19, 2012 |
| EQ 80MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 13, 2016 |
| EQ 105MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 13, 2016 |
| EQ 65MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2018 |
| EQ 115MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2018 |
| EQ 55MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 21, 2019 |
| EQ 75MG BASE | tablet | Prescription | ORAL | AB | May 1, 2020 |
| EQ 100MG BASE | tablet | Prescription | ORAL | AB | May 1, 2020 |
| EQ 50MG BASE | tablet | Prescription | ORAL | AB | May 1, 2020 |
24. BARR LABS INC
Barr Laboratories Inc has filed for 7 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 90MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Mar 17, 2009 |
| EQ 45MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Mar 17, 2009 |
| EQ 135MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Mar 17, 2009 |
| EQ 65MG BASE | tablet, extended release | Discontinued | ORAL | N/A | May 18, 2012 |
| EQ 115MG BASE | tablet, extended release | Discontinued | ORAL | N/A | May 18, 2012 |
| EQ 105MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Apr 26, 2017 |
| EQ 80MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Apr 26, 2017 |
25. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 8 different strengths of generic version for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 80MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2016 |
| EQ 45MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2016 |
| EQ 105MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2016 |
| EQ 135MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2016 |
| EQ 90MG BASE | tablet, extended release | Prescription | ORAL | AB | Sep 28, 2016 |
| EQ 65MG BASE | tablet, extended release | Prescription | ORAL | AB | Mar 16, 2018 |
| EQ 115MG BASE | tablet, extended release | Prescription | ORAL | AB | Mar 16, 2018 |
| EQ 55MG BASE | tablet, extended release | Prescription | ORAL | AB | Dec 19, 2019 |
26. WATSON LABS TEVA
Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 1 generic for Minocycline Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Teva.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE | capsule | Prescription | ORAL | AB | Dec 30, 1991 |